Toxic effects Acute / chronic Reversible / irreversible Immediate / delayed Idiosyncratic - hypersensitivity Local / systemic Target organs.

Slides:



Advertisements
Similar presentations
The main properties of DNA
Advertisements

Toxicological report Bio 464
Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,
AP Biology Regulation of Cell Division.
Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
Is depleted uranium a carcinogen? Keith Baverstock PhD Department of Environmental Science University of Kuopio Finland.
Chemical Carcinogens – workplace risk assessment and health surveillance Tiina Santonen Paide.
McKim Workshop on Strategic Approaches for Reducing Data Redundancy in Cancer Assessment Jay R. Niemelä Technical University of Denmark National Food Institute.
Dose-Response Concept
Experimental pathology refers to the observation of the effects of manipulations on animal models or cell cultures regarding researches on human diseases.
DNA and Gene Expression. DNA Deoxyribonucleic Acid Deoxyribonucleic Acid Double helix Double helix Carries genetic information Carries genetic information.
1 Bacterial Genetics Part II. 2 Review of the Lac Operon Repressors turn off gene –Lac repressor Inducers bind to and inactivate repressors –Allolactose.
What Do Toxicologists Do?
Genomes and mutagenesis. Figure 9.15 The Ames test relies on a mutant bacterial strain that is defective in hisG. - Cannot grow on a medium lacking histidine.
Detecting Mutagens and Carcinogens. introduction - Increased number of chemicals used and present as environmental contaminats, testes for the mutagenicity.
1 Sumol/August 21, 2002 Toxicology& Risk Analysis Sumol Pavittranon, Ph. D. Dept. Of Medical Sciences
Food and Drug Administration Preclinical safety data for “first in human” (FIH) clinical trials in healthy volunteer subjects Oncology Drug Advisory Committee.
Part I - Cloning In General.
ILSI Risk Science Institute Acrylamide Toxicity: Research to Address Key Data Gaps Presented by Dr. Stephen S. Olin ILSI Risk Science Institute.
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Development of a drug Based on: a known active drug known receptor known endogenous ligand Of natural origin: microorganisms Plants Animals.
AP Biology: Chapter 14 DNA Technologies
Determinants of Repeated exposure Toxicity
Chemical-Induced Mutagenesis
AP Biology Regulation of Cell Division AP Biology 1.Coordination of cell division a. A multicellular organism needs to coordinate cell division across.
Multiplication of cells takes place by division of pre- existing cells. Cell multiplication is equally necessary after the birth of the individual for.
28/05/12 Questions (Rispondete alle domande che seguono usando il colore rosso per il testo) Tossicologia - Rubbiani Maristella.
MEDICAL TESTING Doctor requires information Patient sample collection
DNA Technologies.
Basic Aspects and Most Commonly Worldwide Employed and Validated In Vitro Assays Leon F. Stankowski, Jr., PhD Consultant, Genetic Toxicology Genotoxicity.
CA-1 Preclinical Studies Philip Bentley, PhD Vice President Toxicology/Pathology Novartis Pharmaceuticals Corporation Philip Bentley, PhD Vice President.
Chapter 10: Chemical-Induced Mutagenesis. DNA and Mutations A mutation is a permanent change in the DNA. DNA is in our chromosomes and it codes for all.
Gene Expression Control of Gene Expression Activation of a gene that results in the formation of a _________. When transcription occurs a gene is “__________”
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
Laboratory toxicology. Toxicological methods In vitro –Cell cultures –Cell-free systems –Mechanistic In vivo (lab animals) –Acute –Subchronic –Chronic.
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
August 24-26, 2015 Philadelphia, USA
Introduction of Pathology
QSAR in CANCER ASSESSMENT PURPOSE and AGENDA Gilman Veith Duluth MN May 19-21, 2010.
BRCA2: Breast Cancer Susceptibility Gene 2 Lindy Behrend March 4, 2003.
ASTM F748 Selecting Biological Test Methods
Russell D. Owen Wireless Phones Russell D. Owen, Ph.D. Chief, Radiation Biology Branch, Division of Life Sciences CDRH Office of Science and Technology.
McKim Conference on Predictive Toxicology The Inn of Lake Superior Duluth, Minnesota September 16-18, 2008 Toxicity Pathways as an Organizing Concept Gilman.
PHL 472 Chemical Carcinogens Abdelkader Ashour, Ph.D. 2 nd Lecture.
European Patients’ Academy on Therapeutic Innovation Non-clinical development.
Furan-Induced Cytotoxicity, Cell Proliferation, and Tumorgenicity in Mouse Liver Dr. Glenda Moser.
『창의적 예측경영』『 효율적 내실경영 』 Toxicity Lee, sang-hwi Chapter 17.
Toxicogenomics Dr. M. Zdanowicz.
James G. Farrelly, Ph.D. Pharmacology Team Leader Division of Antiviral Drug Products Center for Drug Evaluation and Research Food and Drug Administration.
Acute Toxicity Studies Single dose - rat, mouse (5/sex/dose), dog, monkey (1/sex/dose) 14 day observation In-life observations (body wt., food consumption,
11 Simulating of in vivo metabolism taking into account detoxification logics.
Adaptation & Selection
Alignment table: group 4
Role of genetic and non-genetic mechanisms in furan risk
Regulating the Cell Cycle & Cancer
Conceptual approach for incorporating “omics” technologies and resulting large databases into toxicological evaluation. Data from experiments that evaluate.
CYTOGENETICS CONCEPTS
Susan Makris U.S. EPA, Office of Research and Development
The Genetic Basis of Cancer
Regulation of Cell Division
Bellringer Grab a sheet of paper from the front table. Identify the following structures? 2.___?__ 1.____?____.
Bystander Effects.
Bellringer Grab a sheet of paper from the front table. Identify the following structures? 2.___?__ 1.____?____.
Adaptive Response to Low Dose Radiation
CTD Module 4: Non-Clinical Studies SPC Relevant Scientific information
Cancer: When The Cell Cycle Goes Wrong
Topic 5: When Plans Change
What is environmental toxicology ?
Positive Genetox Findings on a Candidate Pharmaceutical…. Now What
Presentation transcript:

Toxic effects Acute / chronic Reversible / irreversible Immediate / delayed Idiosyncratic - hypersensitivity Local / systemic Target organs

Toxicological Screening Molecular assays DNA damage (eg AP sites) DNA binding (eg adducts) Altered gene expression (Gene arrays) Altered protein synthesis (Proteomics)

DNA Binding

Gene array

Protein 2D gel

Toxicological Screening Bioassays Cell Toxicity Assays (Short Term) Cell Genotoxicity Assays (Short Term) Tissue culture (Primary cells, cell lines) Isolated perfused organs Whole Animal Studies (Medium - Long Term)

Cell Toxicity Assays Trypan Blue Exclusion Neutral Red Uptake ATP Production MTT assay Assays for apoptosis (TUNEL)

In vitro short-term tests for genotoxicity Tests for mutagenesis/carcinogenesis Bacterial mutagenesis e.g. Ames assay Mammalian mutagenesis e.g. Mouse Lymphoma L 5178Y, V79 DNA repair e.g. Sister Chromatid Exchange (SCE) Chromosome damage, Cytogenetics e.g. Chromosome Aberrations (CA), Strand Breakage Cell transformation e.g. BALB/3T3, C3H/10T 1/2

PRINCIPLE OF THE AMES ASSAY Histidine is an amino acid essential for cell growth “Normal” wild-type bacteria make their own histidine: No His Ames strains have defects in the genes that code for histidine synthesis No His No His Mutations may reverse the defects (reversion) + Chemical + His Revertants

Tissue culture

Isolated perfused liver

Isolated perfused lung

in vivo Tests for initiators Skin Tumors in Mice (Sencar) Pulmonary Tumors in Mice (Strain A) Tests for promoters Skin Tumors in Mice (Sencar) Pulmonary Tumors in Mice (Strain A) Altered Foci in Rodent Liver Breast Cancer in Female Rats (Huggins model) NTP Cancer Bioassays Bioassays

in vivo Experimental Design Generally two or more species, equal numbers of each gender Short-term:Acute24-48 h Sub-acute Sub-chronic10% of life-span, 90 days Observe: Food consumption, body weight gain, general appearance, behavior At sacrifice: Organ weights, gross pathology,microscopic examination of major organs, clinical laboratory tests on blood and urine. Other studies if indicated by observations, clinical chemistry or gross lesions. Determine MTD for long-term studies. Bioassays

Long-term:ChronicEntire Life-span Observe: Food consumption, body weight gain, behavior Mortality and morbidity, Cancer At sacrifice: Organ weights, gross pathology, histopathology. More detailed assessment of tumors To define the nature of the toxicity, carcinogencity, NOAEL Bioassays

Biomarkers Biomarkers of Exposure Metabolites (urine, saliva, blood) DNA adducts (peripheral blood lymphocytes) Protein adducts (blood) Biomarkers of Effect Chromosomal aberrations Mutations